Two collaborative projects with Public Research Centers with a global budget of 2.3 million euros focused on the discovery and validation of new biomarkers and epigenetic targets in the treatment of n...
Read moreOncoheroes Biosciences, Inc. (“Oncoheroes”) announced today that the U.S. Food and Drug Administration (FDA) has allowed the Boston-based biotech to proceed with the investigation of two potential...
Read moreLa empresa, dirigida por el doctor Pablo Escribá, ha desarrollado Lam561, un fármaco específico para combatir el glioblastoma y prolongar la esperanza de vida de los pacientes afectados por este ti...
Read moreSpanish biotech OneChain Immunotherapeutics (OCI), has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA)to OC-1, a CAR T therapy against for the treatment of acute lymp...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company presented an ...
Read moreThe journal Science Translational Medicine has published the results of a preclinical study carried out on rodents that shows the efficacy of uric acid in improving the prognosis of ischaemic stroke. ...
Read moreThe new study, led by Eva González-Suárez, head of the Transformation and Metastase Group at the Spanish National Cancer Research Centre (CNIO), describes the behaviour and interaction of these two ...
Read moreAgomab Therapeutics NV ('Agomab') today announced the closing of a $100 million Series C round of financing to support the Phase 2a clinical trial evaluating Agomab's lead drug candidate, AGMB-129, a ...
Read moreAM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacemen...
Read moreOncoheroes Biosciences, a biotech focused on advancing new therapies for childhood cancer, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to dovit...
Read moreEntre los seleccionados de este año se encuentran dos proyectos de CIC bioGUNE. Uno de ellos acercará a la práctica clínica una nueva terapia basada en anticuerpos para frenar la metástasis del c...
Read moreCon motivo del ‘Encuentro de Alto Nivel One Health sobre Resistencia Antimicrobiana’ –celebrado por la Presidencia española del Consejo de la UE–, Farmaindustria y Veterindustria, que represe...
Read more